Blanca M, Romano A, Torres M J, Férnandez J, Mayorga C, Rodriguez J, Demoly P, Bousquet P J, Merk H F, Sanz M L, Ott H, Atanasković-Marković M
Allergy Service, Carlos Haya Hospital, Malaga, Spain.
Allergy. 2009 Feb;64(2):183-93. doi: 10.1111/j.1398-9995.2008.01916.x.
Hypersensitivity reactions to betalactams (BLs) are classified as immediate or nonimmediate. The former usually appear within 1 h of drug-intake and are mediated by specific IgE-antibodies. Nonimmediate reactions are those occurring more than 1 h after drug-intake, and they can be T-cell mediated. The diagnostic evaluation of allergic reactions to BLs has changed over the last 5 years, for several reasons. Major and minor determinants are no longer commercially available for skin testing in many countries. In immediate allergic reactions, the sensitivity of skin testing and immunoassays is decreasing and new in vitro methods, such as the basophil activation test, are gaining importance for diagnosis. For nonimmediate reactions, skin testing appears to be less sensitive than previous results, although more studies need to be carried out in this direction. Nevertheless, the drug provocation test is still necessary for diagnosis.
对β-内酰胺类药物(BLs)的超敏反应分为速发型或非速发型。前者通常在服药后1小时内出现,由特异性IgE抗体介导。非速发型反应是指在服药后1小时以上出现的反应,可由T细胞介导。由于多种原因,在过去5年中,对BLs过敏反应的诊断评估发生了变化。在许多国家,主要和次要决定簇已不再用于皮肤试验的商业供应。在速发型过敏反应中,皮肤试验和免疫测定的敏感性正在下降,而新的体外方法,如嗜碱性粒细胞活化试验,在诊断中越来越重要。对于非速发型反应,皮肤试验似乎比以前的结果敏感性更低,尽管需要在这个方向上进行更多的研究。然而,药物激发试验对于诊断仍然是必要的。